News | July 16, 2025
Waters, BD biosciences unit agree to $17.5 billion merger
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Capricor’s BLA for Deramiocel received Priority Review in March 2025
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
The company’s largest center for medical device applications, serving the entire Asian market
Subscribe To Our Newsletter & Stay Updated
